Global Clinical Trial Imaging Service Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Clinical Trial Imaging Service Market Research Report 2024
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
According to MRAResearch’s new survey, global Clinical Trial Imaging Service market is projected to reach US$ 2281.9 million in 2033, increasing from US$ 1379.4 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Trial Imaging Service market research.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Clinical Trial Imaging Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bioclinica
Parexel International Corporation
Icon
Biomedical Systems Corporation (ERT)
Biotelemetry
Cardiovascular Imaging Technologies
Intrinsic Imaging
Ixico
Radiant Sage
Worldcare Clinical
Micron, Inc
Segment by Type
In-house Imaging Service
Central Imaging Service
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Trial Imaging Service report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Clinical Trial Imaging Service market is projected to reach US$ 2281.9 million in 2033, increasing from US$ 1379.4 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Trial Imaging Service market research.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Clinical Trial Imaging Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bioclinica
Parexel International Corporation
Icon
Biomedical Systems Corporation (ERT)
Biotelemetry
Cardiovascular Imaging Technologies
Intrinsic Imaging
Ixico
Radiant Sage
Worldcare Clinical
Micron, Inc
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Trial Imaging Service report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source